QT
ADMA icon

Quantbot Technologies’s ADMA Biologics ADMA Stock Holding History

Quantbot Technologies’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$179K Buy
19,903
+3,546
+22% +$56K 0.01% 1200
2025
Q4 		$298K Buy
+16,357
New +$276K 0.01% 1118

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Quantbot Technologies's ADMA Position: Q1 2026 in Review

Quantbot Technologies increased its ADMA Biologics (ADMA) stake by 22% in Q1 2026, buying an estimated $56K and bringing the position to 19,903 shares worth $179K. The position accounts for 0.01% of the portfolio, ranked #1200.

Quantbot Technologies first reported a position in ADMA in Q4 2025 and has held it in 2 quarters since. The position peaked at $298K in Q4 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Quantbot Technologies held 19,903 shares of ADMA Biologics worth $179K as of Q1 2026.
  • Quantbot Technologies bought 3,546 ADMA Biologics shares in Q1 2026, an estimated $56K.
  • ADMA Biologics made up 0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1200 holding.
  • Quantbot Technologies first reported a position in ADMA Biologics in Q4 2025 and has held it in 2 quarters since.
  • Quantbot Technologies's ADMA Biologics position peaked at $298K in Q4 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.